Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial

Fig. 3

PCA plot for a T1, b T2 and c T3. Three-dimensional PCA plot displaying each individual serum sample from each timepoint (placebo and FF/VI), accounting for all metabolites. Comp., component; FF/VI, fluticasone furoate/vilanterol trifenatate; PCA, principal component analysis; T1, baseline; T2, Day 15; T3, Day 21

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us